| Peripheral and central nervous mechanisms of nociception, pain, and pain therapy: facts and hypotheses M Zimmermann Advances in pain research and therapy 3, 3-32, 1979 | 181 | 1979 |
| A macro stress testing framework for assessing systemic risks in the banking sector J Henry, C Kok, A Amzallag, P Baudino, I Cabral, M Grodzicki, M Gross, ... ECB Occasional Paper, 2013 | 138 | 2013 |
| Phenotypic heterogeneity in metabolic traits among single cells of a rare bacterial species in its natural environment quantified with a combination of flow cell sorting and … M Zimmermann, S Escrig, T Hübschmann, MK Kirf, A Brand, RF Inglis, ... Frontiers in microbiology 6, 243, 2015 | 80 | 2015 |
| Treament of morphine-induced constipation with oral naloxone L Latasch, M Zimmermann, B Eberhardt, I Jurna Der Anaesthesist 46 (3), 191-194, 1997 | 59 | 1997 |
| From particle self-assembly to functionalized sub-micron protein patterns TM Blättler, A Binkert, M Zimmermann, M Textor, J Vörös, E Reimhult Nanotechnology 19 (7), 075301, 2008 | 52 | 2008 |
| Neurophysiology of nociception, pain and pain therapy M Zimmermann Advances in pain research 2, 13-23, 1979 | 44 | 1979 |
| Central nervous mechanisms modulating pain-related information: do they become deficient after lesions of the peripheral or central nervous system M Zimmermann Pain and central nervous system disease: the central pain syndrome. Raven …, 1991 | 40 | 1991 |
| Opioid constipation: The antagonization of opioid-induced obstipation by naloxone L Latasch, I Jurna, M Zimmermann Dolor 11 (Suppl 1), 47, 1996 | 33 | 1996 |
| Das neue Unbewusste M Spitzer Nervenheilkunde 25 (08), 615-622, 2006 | 27 | 2006 |
| Aufhebung einer Morphin-induzierten Obstipation durch orales Naloxon L Latasch, M Zimmermann, B Eberhardt, I Jurna Der Anaesthesist 46, 191-194, 1997 | 24 | 1997 |
| Back pain: Guidelines for drug therapy. Utilize the therapeutic spectrum R Wörz, G Müller-Schwefe, I Stroehmann, L Zeuner, W Zieglgänsberger, ... MMW Fortschritte der Medizin 142 (5), 27-33, 2000 | 23 | 2000 |
| Guidelines for therapy of pain in cancer patients M Zimmermann, P Drings Pain in the Cancer Patient: Pathogenesis, Diagnosis and Therapy, 1-12, 1984 | 23 | 1984 |
| Substrate and electron donor limitation induce phenotypic heterogeneity in different metabolic activities in a green sulphur bacterium M Zimmermann, S Escrig, G Lavik, MMM Kuypers, A Meibom, ... Environmental Microbiology Reports 10 (2), 179-183, 2018 | 20 | 2018 |
| In vitro activity of taurolidine, chlorophenol-camphor-menthol and chlorhexidine against oral pathogenic microorganisms. M Zimmermann, V Preac-Mursic Arzneimittel-forschung 42 (9), 1157-1159, 1992 | 20 | 1992 |
| Generation of 3-dimensional multi-patches on silica particles via printing with wrinkled stamps D John, M Zimmermann, A Böker Soft Matter 14 (16), 3057-3062, 2018 | 12 | 2018 |
| Evaluation einer stationären nicht operativen Behandlung von akuten, subakuten und chronischen Rückenschmerzen I Haase, K Haase, B Kladny Zeitschrift für Orthopädie und Unfallchirurgie 156 (02), 184-192, 2018 | 11 | 2018 |
| DEAFFERENTATION PAIN-CHAIRMANS INTRODUCTION M Zimmermann Advances in pain research and therapy 5, 661-662, 1982 | 8 | 1982 |
| Oral naloxone antagonizes morphine-induced constipation L Latasch, M Zimmermann, B Eberhardt, I Jurna Anaesthesist 46 (3), 191-194, 1997 | 7 | 1997 |
| Individual aspects of the quality of life of patients with chronic pain. Observational study of treatment with fentanyl-TTS M Zimmermann, I Waap MMW Fortschritte der Medizin 147, 33-40, 2005 | 6 | 2005 |
| The antimicrobial actions of taurolin and other preparations on the pathogenic spectrum in dentoalveolar infections. M Zimmermann, V Preac-Mursic International Journal of Clinical Pharmacology, Therapy, and Toxicology 31 …, 1993 | 4 | 1993 |
